Use of dipeptidyl peptidase IV effectors for lowering the blood glucose level in mammals

  • US 6,303,661 B1
  • Filed: 10/06/1998
  • Issued: 10/16/2001
  • Est. Priority Date: 04/25/1996
  • Status: Expired due to Term
First Claim
Patent Images

1. A method for lowering elevated blood glucose levels in mammals resulting from food intake comprising administering at least one oral administration of a therapeutically effective amount of at least one inhibitor of Dipeptidyl Peptidase (DP IV) or of DP IV-like enzyme activity.

View all claims

    Thank you for your feedback